HealthEquityHQY -0.41%93 EV-to-FCF is 19.53 as of Jul. 11, 2026, which is 66% below its 10-year median of 57.78. GuruFocus rates HQY with a GF Score™ of 93/100 and a GF Value™ of $103.41 (Fairly Valued). The stock has 3 warning signs investors should review. Among 405 Healthcare Providers & Services companies, HealthEquity ranks worse than 55.31% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, HealthEquity's Enterprise Value is $8,611 Mil.
HealthEquity's Free Cash Flow for the trailing twelve months (TTM) ended in Apr. 2026 was $441 Mil. Therefore, HealthEquity's EV-to-FCF for today is 19.53.
The historical rank and industry rank for HealthEquity's EV-to-FCF or its related term are showing as below:
HQY'
s EV-to-FCF Range Over the Past 10 Years
Min: -276.61 Med: 57.78 Max: 1697.42
Current: 19.53
During the past 13 years, the highest EV-to-FCF of HealthEquity was 1697.42. The lowest was -276.61. And the median was 57.78.
HQY's EV-to-FCF is ranked worse than 55.31% of 405
companies
in the Healthcare Providers & Services industry
Industry Median: 17.97
vs HQY: 19.53
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
HealthEquity's PE Ratio (TTM) for today is calculated as:
HealthEquity's share price for today is $94.41.
HealthEquity's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.670.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
HealthEquity EV-to-FCF Related Terms
HealthEquity EV-to-FCF Historical Data
* Premium members only.
The historical data trend for HealthEquity's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, HealthEquity's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HealthEquity EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, HealthEquity's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where HealthEquity's EV-to-FCF falls into.
HealthEquity's current Enterprise Value is $8,611 Mil.
HealthEquity's Free Cash Flow for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $441 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HealthEquity (HQY) has a EV-to-FCF of 19.53 as of Jul. 11, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on HealthEquity and its competitors. This is 66% below median its historical median of 57.78. According to the industry distribution chart, HealthEquity ranks #224 out of 405 companies in the Healthcare Providers & Services industry, placing it in the top 55.3%.
Is HealthEquity's EV-to-FCF too high?
HealthEquity's current EV-to-FCF of 19.53 is 66% below median its 10-year median of 57.78. The Healthcare Providers & Services industry median EV-to-FCF is 17.97. HealthEquity's value of 19.53 is 8.7% above this industry median. Based on the distribution chart, HealthEquity ranks #224 out of 405 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, HealthEquity has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does HealthEquity's EV-to-FCF compare to HNGE and TEM?
According to the Healthcare Providers & Services industry distribution chart, HealthEquity ranks #224 out of 405 companies for EV-to-FCF. This places HealthEquity in the lower half of its industry. The industry median EV-to-FCF is 17.97. HealthEquity's value of 19.53 is 8.7% above this benchmark. While the company's 10-year median is 57.78 vs. the industry median of 17.97, HealthEquity has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.97, based on 405 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HealthEquity's current EV-to-FCF of 19.53 is 8.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on HealthEquity and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HealthEquity's current EV-to-FCF is 19.53, which is 66% below median its own 10-year median of 57.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthEquity stock overvalued right now?
Based on GuruFocus' analysis, HealthEquity (HQY) is currently considered Fairly Valued. The stock's GF Value™ is $103.41, compared to a current price of $94.41 — trading 8.7% below its estimated fair value. The current EV-to-FCF is 19.53, which is 66% below median its 10-year median of 57.78 and 8.7% above the Healthcare Providers & Services industry median of 17.97. HealthEquity's overall GF Score™ is 93/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For HealthEquity (HQY), the current EV-to-FCF is 19.53 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HealthEquity (HQY) Overvalued in 2026?
Based on GuruFocus' analysis, HealthEquity stock appears to be undervalued.
The current stock price of $94.41 is trading 8.7% below its estimated GF Value™ of $103.41.
GuruFocus considers HealthEquity to be Fairly Valued.
Key valuation signals for HQY:
EV-to-FCF: 19.53 (66% below median its 10-year median of 57.78)
GF Value™: $103.41 vs. price of $94.41 (8.7% below fair value)
Industry Position: 8.7% above the Healthcare Providers & Services median (#224 of 405)
No single metric tells the full story. See the HQY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
93GF Score
Get the complete analysis for HQY
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HQY has been successfully added to your 
